Intrexon | XON - Trade Debtors


Intrexon reported $1.02M in Trade Debtors for its fiscal quarter ending in June of 2024.





Trade Debtors Change Date
Agenus USD 22.34M 107K Mar/2026
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 10.23B 1.09B Jun/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 8.56M 7.13M Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Incyte USD 1.13B 73.7M Jun/2026
Intrexon USD 1.02M 559K Jun/2024
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
MannKind USD 43.21M 15.07M Jun/2026
Merck USD 12.21B 435M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Thermo Fisher Scientific USD 9.45B 247M Jun/2026
Veracyte USD 54.18M 4.06M Jun/2026
Xencor USD 42.23M 30.23M Jun/2026